Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Lamivudine could represent an important new option for millions of patients with diabetic macular edema (DME), a condition which causes fluid to build up in the retina of the eye.
In a new National Institutes of Health-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier.
Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes, which is associated with a range of eye diseases such as diabetic retinopathy..
New data demonstrate how social determinants of health can fuel disparities in monitoring for diabetic retinopathy for patients of different racial and ethnic groups.
Researchers are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak or become blocked.
A new study at the University of Houston College of Optometry will track the health of patients with prediabetes and diabetes to find out who might develop eye problems and be at risk for future vision loss.
Researchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center are studying a new, revolutionary treatment for diabetic retinopathy that could change the prognosis for these patients.
A five-year grant will fund research investigating biological processes that contribute to defects in immune response in the eyes of those with diabetes and identify methods to reverse them.
Researchers at Indiana University School of Optometry found that individuals are at different risks for retinal damage from diabetes, with certain ethnic groups and males being at a greater risk.
A study of children and youth with diabetes concludes that diabetic eye exams using artificial intelligence (AI) increase completion rates of screenings to detect diabetic eye disease.